Yüklüyor......
Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease
Diabetic kidney disease (DKD) is a widespread chronic microvascular complication of diabetes mellitus (DM), affects almost 30–50% of patients, and represents a leading cause of death of DM. Serotonin or 5-hydroxytryptamine (5-HT) is a multifunctional bioamine that has crucial roles in many physiolog...
Kaydedildi:
| Yayımlandı: | J Diabetes Res |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Hindawi
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5591914/ https://ncbi.nlm.nih.gov/pubmed/28929122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/7680576 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|